xiretsapharm.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.xiretsapharm.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title HOME |
Description Building the Building the future of
Keywords N/A
Server Information
WebSite xiretsapharm faviconxiretsapharm.com
Host IP 185.230.63.186
Location -
Related Websites
Site Rank
More to Explore
xiretsapharm.com Valuation
US$1,194
Last updated: 2023-05-01 07:14:28

xiretsapharm.com has Semrush global rank of 0. xiretsapharm.com has an estimated worth of US$ 1,194, based on its estimated Ads revenue. xiretsapharm.com receives approximately 137 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, xiretsapharm.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,194
Daily Ads Revenue US$1
Monthly Ads Revenue US$33
Yearly Ads Revenue US$396
Daily Unique Visitors 9
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
xiretsapharm.com. A 3599 IP: 185.230.63.186
xiretsapharm.com. A 3599 IP: 185.230.63.171
xiretsapharm.com. A 3599 IP: 185.230.63.107
xiretsapharm.com. NS 86400 NS Record: ns2.wixdns.net.
xiretsapharm.com. NS 86400 NS Record: ns3.wixdns.net.
xiretsapharm.com. MX 3600 MX Record: 10 aspmx3.googlemail.com.
xiretsapharm.com. MX 3600 MX Record: 5 alt1.aspmx.l.google.com.
xiretsapharm.com. MX 3600 MX Record: 1 aspmx.l.google.com.
xiretsapharm.com. MX 3600 MX Record: 10 aspmx2.googlemail.com.
xiretsapharm.com. MX 3600 MX Record: 5 alt2.aspmx.l.google.com.
HtmlToTextCheckTime:2023-05-01 07:14:28
top of page HOME TECH ANTIBIOTIC RESISTANCE ABOUT US LEADERSHIP CONTACT TECHNOLOGY Building the future of antibiotics. Introducing the first new class of broad-spectrum antibiotic developed in over fifty years. Antiinfective Conjugated Electrolytes (ACEs) are a paradigm-changing platform that demonstrate unprecedented activity against Gram-positive and Gram-negative bacteria, as well as certain pathogenic fungi. Their modular design enables rapid derivatization, simple synthesis and a flexible matrix of opportunities. Negligible cross-resistance ensures a long marketable lifetime and reduces the risk for treatment failures. A global threat as great as climate change. 700,000 people die each year from antibiotic resistance with 10 million annual projected deaths by 2050. ​ Resistance threatens the very fabric of modern society. Organ transplants, cancer treatments and all routine surgeries will become risky as resistance to last-resort antibiotics render infections untreatable. ​
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 23 Oct 2021 22:17:32 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.xiretsapharm.com/
strict-transport-security: max-age=120
x-wix-request-id: 1635027451.992304064817623176
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=42
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVhT9gRHUF6iCEZerWBFcnqX,m0j2EEknGIVUW/liY8BLLpKOvBhYRuLEqdCLHFrW+6dGkFvVdT2Nq6f3Hedj7ewB,2d58ifebGbosy5xc+FRalqUdStJUQYCoXaMzrWi5j18q/PImUFL6I8I7TnNg361jRlQJWTlXr4caWr6VrNcSnA==,2UNV7KOq4oGjA5+PKsX47EG2gX3EwxtKlWgE7qSEHjJYgeUJqUXtid+86vZww+nL,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,iNzairCM74Jm+18Ga2HaNa1QW6cClwAshMzhVuOU+IMaWyug/ZdHQ36uOAkr89T0,UvY1uiXtmgas6aI2l+unv6WnrAUC8c0/g/RE016ADa9ta29mWhxLATPlnVpkDQViWIHlCalF7YnfvOr2cMPpyw==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 23 Oct 2021 22:17:32 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1635027452.1923042745667119097
content-language: en
strict-transport-security: max-age=120
age: 0
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=42; Max-Age=20; Expires=Sat, 23 Oct 2021 22:17:52 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YWbXqbGGG7kZMhZ9py6aBaQ=,6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkViozyX1iilefXjG31S4IO7n,m0j2EEknGIVUW/liY8BLLp4sYwYx2UgZC4DZhzpOwcUa0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalvIP6sOVZraqlBjSeYOYaMhxeaZM/xm7OlFOkq9iOn/lusCem2qDW2ksmmawi3xOGw==,2UNV7KOq4oGjA5+PKsX47EG2gX3EwxtKlWgE7qSEHjJYgeUJqUXtid+86vZww+nL,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,LWZ6Tylfijl32cnmU7+qjNC7FzGtZYD/YbnoLaXRbKJYgeUJqUXtid+86vZww+nL,UvY1uiXtmgas6aI2l+unv+IuMGDPR0/rQ4MEmQyhZxYwjADpzaxAQP5M3ranZL0u,LWZ6Tylfijl32cnmU7+qjNC7FzGtZYD/YbnoLaXRbKJYgeUJqUXtid+86vZww+nL,WcrWvzU6+v56AFbpVWES8sqnCaMNR5Megd/VqgVpxGAaWyug/ZdHQ36uOAkr89T0,LoUK8/saGAmOxZWtpubo2iTOnK3GmbK6QcBXwd5Fv/q9npgCEMxXklZnDi6iDz1oQ7rk7TXvuTfBINGXW2UFmw==,WcrWvzU6+v56AFbpVWES8sqnCaMNR5Megd/VqgVpxGAaWyug/ZdHQ36uOAkr89T0,qJS91GsscGZlb16v+8nwmJzpFyIuefO9QJi+1LCj8MQPUN6zYCeYUhP+LoeE7OiY,/a5ccLSK1HEmwPNg/x6OujZ3nNzPi/JTVZTtFE8718bgYKJLjZwkwRuJhXOBWj8MuCA8Ys03TlHQEH/w/nrRKA==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e931319699711d2db308d74a7d3e09751149bffdc5b8f870f8994326a41d4761c9121436b5e410421529af24689a54fbe4fdfa; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10
xiretsapharm.com Whois Information
Domain Name: XIRETSAPHARM.COM
Registry Domain ID: 2429203646_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-09-02T19:32:02Z
Creation Date: 2019-09-02T04:26:07Z
Registry Expiry Date: 2023-09-02T04:26:07Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS2.WIXDNS.NET
Name Server: NS3.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-12T07:31:48Z <<<